0001562180-15-000504.txt : 20150619 0001562180-15-000504.hdr.sgml : 20150619 20150619110929 ACCESSION NUMBER: 0001562180-15-000504 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150617 FILED AS OF DATE: 20150619 DATE AS OF CHANGE: 20150619 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tokai Pharmaceuticals Inc CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 255 STATE STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-225-4348 MAIL ADDRESS: STREET 1: 255 STATE STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yanchik Joseph A., III CENTRAL INDEX KEY: 0001618154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 15941647 MAIL ADDRESS: STREET 1: C/O AILERON THERAPEUTICS INC. STREET 2: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2015-06-17 false 0001404281 Tokai Pharmaceuticals Inc TKAI 0001618154 Yanchik Joseph A., III C/O TOKAI PHARMACEUTICALS, INC. 255 STATE STREET, 6TH FLOOR BOSTON MA 02109 true false false false Stock Option (right to buy) 14.04 2015-06-17 4 A false 12000.00 0.00 A 2025-06-16 Common Stock 12000.00 12000.00 D This option vests with respect to 100% of the shares underlying the option on June 17, 2016 subject to his continued service on Tokais Board of Directors. /s/ Cindy Driscoll, Attorney-in-Fact 2015-06-19